Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Johnson & Johnson’s prostate cancer drug shrinks tumors in early-stage trial

Johnson & Johnson’s prostate cancer drug shrinks tumors in early-stage trial

We haven't written up this one. Investing.com has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at investing.com →

More in Health & Medicine

More from Saturday 24 October →